Addpharma
CompanyROR
Trials
Phase 3, Completed, 290 people, 23 Nov 2021
Phase 2, Completed, 176 people, 6 Jan 2020
Phase 3, Completed, 131 people, 8 Nov 2019
Phase 1, Completed, 88 people, 10 Jun 2019
Phase 3, Completed, 180 people, 13 Mar 2019
Phase 1, Completed, 52 people, 31 Jan 2019
Phase 1, Completed, 52 people, 5 Dec 2018